AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹338 Cr | ₹-4.04 Cr | ₹95 Cr | ₹-253 Cr | ₹123 Cr |
What is the latest Consolidated Net Profit of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹338 Cr |
| Mar2025 | ₹-4.04 Cr |
| Mar2024 | ₹95 Cr |
| Mar2023 | ₹-253 Cr |
| Mar2022 | ₹123 Cr |
How is Consolidated Net Profit of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹338 Cr | Positive | |
| Mar2025 | ₹-4.04 Cr | Negative | |
| Mar2024 | ₹95 Cr | Positive | |
| Mar2023 | ₹-253 Cr | Negative | |
| Mar2022 | ₹123 Cr | - | |
Compare Consolidated Net Profit of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹12,926.5 Cr | 7.5% | 9% | 66.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 7.5% |
9% |
66.6% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses